What do Analysts Say about Amicus Therapeutics, Inc.(NASDAQ:FOLD) : Orange(NYSE:ORAN)

0
3

Amicus Therapeutics, Inc. (FOLD) will report its next earnings on May 07 BMO. The company reported the earnings of $-0.34/Share in the last quarter where the estimated EPS by analysts was $-0.28/share. The difference between the expected and actual EPS was $-0.06/share, which represents an Earnings surprise of -21.4%.

Many analysts are providing their Estimated Earnings analysis for Amicus Therapeutics, Inc. and for the current quarter 12 analysts have projected that the stock could give an Average Earnings estimate of $-0.26/share. These analysts have also projected a Low Estimate of $-0.33/share and a High Estimate of $-0.15/share.

These analysts also forecasted Growth Estimates for the Current Quarter for FOLD to be 23.5%. They are projecting Next Quarter growth of 12.5%. For the next 5 years, Amicus Therapeutics, Inc. is expecting Growth of 39.98% per annum, whereas in the past 5 years the growth was 28.38% per annum.

Some buy side analysts are also providing their Analysis on Amicus Therapeutics, Inc., where 4 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.67 and Average Volume (3 months) is 3.44 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -38.4%. The Return on Equity (ROE) value stands at -64.1%. While it’s Return on Investment (ROI) value is -55.1%.

While looking at the Stock’s Performance, Amicus Therapeutics, Inc. currently shows a Weekly Performance of 0%, where Monthly Performance is 7.37%, Quarterly performance is 36.05%, 6 Months performance is 20.36% and yearly performance percentage is 12.51%. Year to Date performance value (YTD perf) value is 30.18%. The Stock currently has a Weekly Volatility of 6.14% and Monthly Volatility of 5.50%.

Many analysts are providing their Estimated Earnings analysis for Orange and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

Some buy side analysts are also providing their Analysis on Orange, where 3 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.45 and Average Volume (3 months) is 832.83 million. The company’s P/E (price to earnings) ratio is 10.82 and Forward P/E ratio of 9.82.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 5.6%.

While looking at the Stock’s Performance, Orange currently shows a Weekly Performance of 9.78%, where Monthly Performance is 1.66%, Quarterly performance is -10.53%, 6 Months performance is -25.02% and yearly performance percentage is -18.63%. Year to Date performance value (YTD perf) value is -16.18%. The Stock currently has a Weekly Volatility of 1.60% and Monthly Volatility of 2.05%.

SHARE